Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 12  •  04:00PM ET
94.03
Dollar change
-0.22
Percentage change
-0.23
%
IndexS&P 500 P/E25.96 EPS (ttm)3.62 Insider Own0.11% Shs Outstand1.28B Perf Week1.22%
Market Cap120.61B Forward P/E15.47 EPS next Y6.08 Insider Trans-0.25% Shs Float1.28B Perf Month1.21%
Enterprise Value141.34B PEG4.39 EPS next Q1.31 Inst Own86.47% Short Float1.03% Perf Quarter6.26%
Income4.66B P/S3.53 EPS this Y2.51% Inst Trans0.13% Short Ratio1.81 Perf Half Y1.84%
Sales34.20B P/B2.52 EPS next Y8.00% ROA5.16% Short Interest13.23M Perf YTD17.71%
Book/sh37.36 P/C14.85 EPS next 5Y5.92% ROE9.72% 52W High96.25 -2.31% Perf Year3.34%
Cash/sh6.33 P/FCF22.74 EPS past 3/5Y-1.03% 0.39% ROIC6.29% 52W Low79.29 18.59% Perf 3Y7.94%
Dividend Est.2.77 (2.95%) EV/EBITDA15.26 Sales past 3/5Y1.91% 3.01% Gross Margin59.81% Volatility2.10% 1.85% Perf 5Y-11.07%
Dividend TTM2.81 (2.99%) EV/Sales4.13 EPS Y/Y TTM22.08% Oper. Margin18.47% ATR (14)1.75 Perf 10Y34.37%
Dividend Ex-DateSep 26, 2025 Quick Ratio1.50 Sales Y/Y TTM4.98% Profit Margin13.63% RSI (14)57.21 Recom2.18
Dividend Gr. 3/5Y3.57% 5.33% Current Ratio2.01 EPS Q/Q0.54% SMA201.50% Beta0.79 Target Price98.33
Payout77.47% Debt/Eq0.60 Sales Q/Q8.38% SMA502.87% Rel Volume1.00 Prev Close94.25
Employees95000 LT Debt/Eq0.55 EarningsAug 19 BMO SMA2007.25% Avg Volume7.31M Price94.03
IPONov 21, 1977 Option/ShortYes / Yes EPS/Sales Surpr.2.53% 2.38% Trades Volume7,333,750 Change-0.23%
Date Action Analyst Rating Change Price Target Change
Jun-30-25Upgrade Wolfe Research Underperform → Peer Perform
Jun-16-25Initiated Leerink Partners Outperform $110
Mar-04-25Upgrade Citigroup Neutral → Buy $92 → $107
Oct-10-24Upgrade RBC Capital Mkts Sector Perform → Outperform $98 → $105
Aug-21-24Reiterated Oppenheimer Perform $92 → $94
Aug-15-24Upgrade UBS Sell → Neutral $76 → $90
Aug-14-24Downgrade Stifel Buy → Hold $100 → $85
May-30-24Initiated Goldman Sell $83
Jul-19-23Initiated Robert W. Baird Neutral $90
Jun-30-23Initiated CL King Buy $106
Sep-11-25 07:57AM
06:30AM
Sep-10-25 08:56AM
07:20AM
06:20AM
04:53AM Loading…
04:53AM
Sep-05-25 09:45AM
08:50AM
06:05AM
06:00AM
Sep-04-25 02:20PM
12:15PM
06:00AM
Sep-03-25 08:49AM
05:55AM
02:55AM Loading…
02:55AM
Sep-02-25 11:13AM
11:06AM
08:45AM
Sep-01-25 12:11PM
Aug-30-25 04:05AM
Aug-29-25 11:22AM
07:00AM
Aug-28-25 03:17PM
08:48AM
Aug-26-25 09:50AM
Aug-25-25 05:41PM
05:00AM
04:04AM
Aug-24-25 11:14AM
07:00AM Loading…
Aug-23-25 07:00AM
Aug-22-25 09:53AM
08:12AM
04:10AM
Aug-21-25 04:29PM
08:15AM
08:05AM
08:05AM
Aug-20-25 06:06PM
04:18PM
11:20AM
10:30AM
10:30AM
10:15AM
09:40AM
09:20AM
08:05AM
03:03AM
Aug-19-25 05:01PM
04:33PM
04:25PM
04:02PM
03:41PM
02:59PM
01:45PM
12:21PM
12:05PM
12:01PM
11:40AM
11:21AM
09:48AM
09:45AM
09:35AM
09:30AM
09:10AM
08:46AM
08:39AM
08:36AM
07:55AM
07:41AM
07:27AM
07:26AM
06:52AM
06:46AM
06:45AM
06:32AM
05:59AM
05:45AM
04:57AM
04:05AM
03:14AM
Aug-18-25 04:31PM
Aug-17-25 07:35AM
Aug-15-25 04:32PM
04:32PM
10:00AM
Aug-14-25 06:00PM
05:45PM
04:15PM
10:25AM
09:15AM
08:33AM
06:00AM
04:04AM
Aug-13-25 09:21AM
08:37AM
07:32AM
06:05AM
Aug-12-25 05:10PM
12:30PM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIIL HARRY SKIPEVP & President CardiovascularSep 03 '25Sale91.588,605788,04835,615Sep 05 04:18 PM
KIIL HARRY SKIPOfficerSep 03 '25Proposed Sale91.588,605788,049Sep 03 03:23 PM
Jellison William RDirectorAug 22 '25Buy92.732,500231,8252,500Aug 25 05:18 PM
Jellison William RDirectorAug 25 '25Buy92.372,500230,9255,000Aug 25 05:18 PM
Walter Matthew R.SVP, Chief HR OfficerAug 01 '25Option Exercise23.913,14275,11432,804Aug 04 04:21 PM
Wall Brett A.EVP & Pres NeuroscienceAug 01 '25Option Exercise0.0015,249066,531Aug 04 04:20 PM
Smith Gregory LEVP Global Ops & Supply ChainAug 01 '25Option Exercise0.0011,328083,071Aug 04 04:19 PM
Martha GeoffreyChairman and CEOAug 01 '25Option Exercise32.2198,3243,166,800284,923Aug 04 04:18 PM
Marinaro MichaelEVP, Pres MedSurg and AmericasAug 01 '25Option Exercise25.249,661243,82857,628Aug 04 04:17 PM
KIIL HARRY SKIPEVP & President CardiovascularAug 01 '25Option Exercise0.0010,457051,775Aug 04 04:16 PM
Blomquist Denise L.Chief Accounting OfficerAug 01 '25Option Exercise32.2251816,69212,671Aug 04 04:15 PM
Salmon SeanOfficerJun 06 '25Proposed Sale86.8118,3781,595,469Jun 06 02:43 PM
Walter Matthew R.SVP, Chief HR OfficerJan 27 '25Option Exercise74.841,337100,06126,997Jan 28 05:10 PM
Marinaro MichaelEVP & President, Surgical OUJan 27 '25Option Exercise74.842,345175,50043,323Jan 28 05:09 PM
Martha GeoffreyChairman and CEOJan 27 '25Option Exercise74.8434,7412,600,016216,954Jan 28 05:07 PM
Wall Brett A.EVP & Pres NeuroscienceJan 24 '25Option Exercise78.0012,437970,08653,416Jan 27 05:35 PM
Wall Brett A.EVP & Pres NeuroscienceJan 24 '25Sale90.0012,4371,119,33040,979Jan 27 05:35 PM
Wall Brett A.OfficerJan 24 '25Proposed Sale90.0012,4371,119,330Jan 24 02:34 PM
Wall Brett A.EVP & Pres NeuroscienceJan 08 '25Option Exercise74.846,850512,65450,558Jan 10 04:48 PM
Wall Brett A.EVP & Pres NeuroscienceJan 08 '25Sale80.419,850792,03840,708Jan 10 04:48 PM
Wall Brett A.OfficerJan 08 '25Proposed Sale80.419,850792,038Jan 08 09:52 AM
PARKHILL KAREN LFormer DirectorOct 31 '24Proposed Sale89.7330,0002,691,794Oct 31 03:21 PM
PARKHILL KAREN LFormer DirectorOct 30 '24Proposed Sale90.5815,0001,358,740Oct 30 04:11 PM
PARKHILL KAREN LFormer BODOct 29 '24Proposed Sale91.1615,0001,367,348Oct 29 03:26 PM
PARKHILL KAREN LFormer DirectorOct 24 '24Proposed Sale92.4922,7122,100,633Oct 24 04:01 PM
PARKHILL KAREN LFormer DirectorOct 23 '24Proposed Sale91.7623,8482,188,205Oct 23 04:30 PM
PARKHILL KAREN LFormer BODOct 18 '24Proposed Sale91.7448,8254,479,310Oct 18 04:24 PM
PARKHILL KAREN LFormer BODOct 17 '24Proposed Sale89.8755,1794,958,718Oct 17 03:35 PM